NTLA: Wutah pendapatan triwulanan Intellia

Logo grafis Intellia Corp (NTLA)

The absence of its own commercial products makes Intellia Therapeutics (NTLA) dependent on external investments and partner payments. However, its status as a leader in genome editing and its patent protection create a powerful barrier for competitors. The quarterly revenue growth rate confirms this trend, where the value -48.40 denotes the current figure. Growth is driven by successful in vivo clinical trials and FDA regulatory approval.

NTLA Tambahing pendapatan triwulanan Intellia Therapeutics Inc (04.07.2022 - 20.11.2026)

Rincian metrik komprehensif lan analitis Intellia Therapeutics, Inc. (NTLA)

- rega saham lan target rega konsensus:
- rincian dhuwit lan gerakan dhuwit:
Analisis dhasar perusahaan:Intellia Corp - NTLA
Produk seri intelliatx.com

For Intellia Therapeutics (NTLA), whose market capitalization depends on the progress of CRISPR therapy and the commercialization of gene medicines, revenue dynamics reflect the pace of intellectual property monetization. The smoothed percentage growth of quarterly revenue measures sales momentum over three months, allowing investors to differentiate an expansion phase from stagnation and evaluate the efficiency of the operating model through the analysis of this chart.

Pesaing Intellia Therapeutics (NTLA)

TEM - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal qiagen.com QGEN|IONS: Wutah pendapatan triwulanan|Repligen Corp - Tambahing pendapatan triwulanan|RNA (Avidity Corp) - Wutah pendapatan triwulanan|CRISPR Therapeutics Corp - Dinamika pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal genedx.com (WGS)|Wutah pendapatan triwulanan ultragenyx.com (RARE)|Wutah pendapatan triwulanan BEAM (Beam Therapeutics Inc)|Sarepta Therapeutics Inc (SRPT) - Tingkat wutah pendapatan sajrone kuartal|twistbioscience.com - Wutah pendapatan triwulanan|10x Genomics, Inc. - Owah-owahan dodolan kuartal marang kuartal|STOK: Wutah pendapatan triwulanan|BLFS - Tingkat wutah dodolan sajrone kuartal|Wutah dodolan triwulanan WVE|MAZE: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Sionna Corp (SION)|Tingkat wutah dodolan sajrone kuartal Prime Medicine Bio|Wutah pendapatan triwulanan TSHA (Taysha Gene Therapies Inc)|Wutah pendapatan triwulanan uniqure.com QURE|MeiraGTx Holdings - Wutah pendapatan triwulanan|RGNX - Wutah pendapatan triwulanan|SLDB (Solid Corp) - Wutah dodolan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Ocugen Corp OCGN|PACB (Pacific Biosciences) - Wutah pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal BNTC|Wutah pendapatan triwulanan DSGN|Wutah dodolan triwulanan Rocket Pharma RCKT|Tingkat wutah dodolan sajrone kuartal FDMT|Wutah pendapatan triwulanan Lexeo Therapeutics LXEO|KRRO - Wutah pendapatan kuartal marang kuartal|EDIT (Editas Medicine, Inc.) - Wutah dodolan kuartal marang kuartal|SLN: Wutah pendapatan triwulanan|ProQR - Tambahing pendapatan triwulanan|CDXS (Codexis) - Wutah pendapatan triwulanan|Sangamo (SGMO) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan NAUT|Wutah dodolan triwulanan Metagenomi, Inc. MGX|Wutah pendapatan kuartal marang kuartal Precision BioSciences DTIL|Tambahing pendapatan triwulanan GBIO|BOLD - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Exicure Inc. XCUR|Imunon, Inc. (IMNN) - Wutah pendapatan kuartal marang kuartal|RXi Pharmaceuticals - Tambahing pendapatan triwulanan|MBIO (Mustang Bio) - Wutah pendapatan triwulanan|Wutah dodolan kuartal marang kuartal RNAZ (transcodetherapeutics.com)|Wutah pendapatan kuartal marang kuartal Bionano (BNGO)|Applied DNA Sciences - Wutah dodolan kuartal marang kuartal|Wutah pendapatan triwulanan BLUE (bluebirdbio.com)|ImmunoPrecise Antibodies (IPA) - Tingkat wutah pendapatan sajrone kuartal|omegatherapeutics.com - Wutah pendapatan triwulanan|Owah-owahan pendapatan dibandhingake kuartal kepungkur Singular Genomics Systems Inc (OMIC)|RGLS: Wutah pendapatan triwulanan|Syros Pharmaceuticals, Inc (SYRS) - Wutah pendapatan triwulanan|TBIO (telesisbio.com) - Wutah pendapatan triwulanan|TCON: Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal Unity Biotechnology, Inc (UBX)